BIOMAT Database Logo BIOMAT Database Logo

Acid treatment of platelets as a simple procedure for distinguishing platelet-specific antibodies from anti-HLA antibodies: comparison with chloroquine treatment. 1990

Y Kurata, and M Oshida, and H Take, and T Furubayashi, and H Mizutani, and Y Tomiyama, and T Yonezawa, and S Tarui
Department of Blood Transfusion, Osaka University Hospital, Japan.

The identification of antibodies to platelet-specific antigens is important for correctly diagnosing neonatal alloimmune thrombocytopenia, posttransfusion purpura and refractoriness due to platelet-specific antibodies. However, the serologic identification of these platelet-specific antibodies is complicated by the presence of anti-HLA antibodies. We examined and compared the diagnostic usefulness of acid-treated and chloroquine-treated platelets for the discrimination of platelet-specific antibodies from anti-HLA antibodies. The viability of acid-treated platelets is 83.4%, which is better than that of chloroquine-treated platelets (52.6%). The antigenicity of HLA class I antigens of acid-treated platelets was significantly reduced compared with that of PBS- or chloroquine-treated platelets. On the other hand, platelet surface glycoprotein Ib and glycoprotein IIb/IIIa, and platelet-specific antigens were stable following acid or chloroquine treatment. Chloroquine-treated platelets were not suitable targets for analysis by immunofluorescence flow cytometry because of nonspecific fluorescence derived from platelet damage. We conclude that acid-treated platelets are more suitable targets than chloroquine-treated platelets for screening for platelet-specific antibodies and also for analyses of the specificity of platelet-specific antibodies.

UI MeSH Term Description Entries
D008722 Methods A series of steps taken in order to conduct research. Techniques,Methodological Studies,Methodological Study,Procedures,Studies, Methodological,Study, Methodological,Method,Procedure,Technique
D010980 Platelet Membrane Glycoproteins Surface glycoproteins on platelets which have a key role in hemostasis and thrombosis such as platelet adhesion and aggregation. Many of these are receptors. PM-GP,Platelet Glycoprotein,Platelet Membrane Glycoprotein,PM-GPs,Platelet Glycoproteins,Glycoprotein, Platelet,Glycoprotein, Platelet Membrane,Glycoproteins, Platelet,Glycoproteins, Platelet Membrane,Membrane Glycoprotein, Platelet,Membrane Glycoproteins, Platelet,PM GP
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D002738 Chloroquine The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses. Aralen,Arechine,Arequin,Chingamin,Chlorochin,Chloroquine Sulfate,Chloroquine Sulphate,Khingamin,Nivaquine,Sulfate, Chloroquine,Sulphate, Chloroquine
D002951 Citrates Derivatives of CITRIC ACID.
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006680 HLA Antigens Antigens determined by leukocyte loci found on chromosome 6, the major histocompatibility loci in humans. They are polypeptides or glycoproteins found on most nucleated cells and platelets, determine tissue types for transplantation, and are associated with certain diseases. Human Leukocyte Antigen,Human Leukocyte Antigens,Leukocyte Antigens,HL-A Antigens,Antigen, Human Leukocyte,Antigens, HL-A,Antigens, HLA,Antigens, Human Leukocyte,Antigens, Leukocyte,HL A Antigens,Leukocyte Antigen, Human,Leukocyte Antigens, Human
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Y Kurata, and M Oshida, and H Take, and T Furubayashi, and H Mizutani, and Y Tomiyama, and T Yonezawa, and S Tarui
[Reactivity of platelet-specific and HLA antibodies with chloroquine-treated thrombocytes].
January 1987, Beitrage zu Infusionstherapie und klinische Ernahrung,
Y Kurata, and M Oshida, and H Take, and T Furubayashi, and H Mizutani, and Y Tomiyama, and T Yonezawa, and S Tarui
Chloroquine removal of HLA antigens from platelets for the platelet immunofluorescence test.
January 1985, Vox sanguinis,
Y Kurata, and M Oshida, and H Take, and T Furubayashi, and H Mizutani, and Y Tomiyama, and T Yonezawa, and S Tarui
HLA-selected platelets for platelet refractory patients with HLA antibodies: a single-center experience.
March 2019, Transfusion,
Y Kurata, and M Oshida, and H Take, and T Furubayashi, and H Mizutani, and Y Tomiyama, and T Yonezawa, and S Tarui
A specific assay for anti-HLA antibodies: application to platelet donor selection.
November 1987, Blood,
Y Kurata, and M Oshida, and H Take, and T Furubayashi, and H Mizutani, and Y Tomiyama, and T Yonezawa, and S Tarui
Simple method for differentiating between HLA and platelet-specific antibodies by flow cytometry.
December 1991, American journal of hematology,
Y Kurata, and M Oshida, and H Take, and T Furubayashi, and H Mizutani, and Y Tomiyama, and T Yonezawa, and S Tarui
[Expression of anti-platelet glycoprotein specific antibodies and anti-HLA antibodies in idiopathic thrombocytopenic purpura].
August 2009, Zhongguo shi yan xue ye xue za zhi,
Y Kurata, and M Oshida, and H Take, and T Furubayashi, and H Mizutani, and Y Tomiyama, and T Yonezawa, and S Tarui
Specific interaction of HLA antibodies (eluates) with washed platelets.
March 1977, British journal of haematology,
Y Kurata, and M Oshida, and H Take, and T Furubayashi, and H Mizutani, and Y Tomiyama, and T Yonezawa, and S Tarui
A megakaryocyte with no platelets: anti-platelet antibodies, apoptosis, and platelet production.
January 2013, Platelets,
Y Kurata, and M Oshida, and H Take, and T Furubayashi, and H Mizutani, and Y Tomiyama, and T Yonezawa, and S Tarui
A survey of platelet serology in UK laboratories (1987): an assessment of the efficacy of using chloroquine-treated platelets to distinguish between platelet-specific and anti-HLA antibodies. The UK Platelet and Granulocyte Serology Working Group.
January 1990, Clinical and laboratory haematology,
Y Kurata, and M Oshida, and H Take, and T Furubayashi, and H Mizutani, and Y Tomiyama, and T Yonezawa, and S Tarui
Platelet transfusion refractoriness associated with two rare platelet-specific alloantibodies (anti-Baka and anti-PlA2) and multiple HLA antibodies.
January 1988, Transfusion,
Copied contents to your clipboard!